We turned motivational interviewing into a 24/7 companion—for the moments when adherence, cravings, or doubt show up at 2 a.m., not 2 p.m.
A few years back, our joint work with UCSF proved something important: a chatbot can deliver real MI, not a gimmick. In that peer-reviewed study, users hit a 13/15 MI-comprehensiveness score, 44% completed a quit plan, 26% initiated treatment, and 15% reported cessation at 3 months. That’s substance. Not sizzle. (Paper available on request.)
Since then, we rebuilt the stack with GenAI end-to-end. What changed?
•Continuous, MI-consistent dialogue that adapts to readiness in real time—available 24/7.
•Precision routing into evidence-based interventions (EBSCIs/MAT/CBT) and care navigation—no dead ends.
•Longitudinal behavior models to predict drop-off risk and trigger timely outreach.
•Deployment options for health plans and IDNs with auditability, guardrails, and integration.
Why this matters to payers and health systems:
•Adherence ≠ reminders. It’s readiness timing access. MI unlocks all three.
•Care teams work at the top of their license while the agent scales the hard, repetitive conversations.
•Metrics that move contracts: quit-plan creation, treatment initiation, appointment adherence, and sustained behavior change.
We’re now seeing patient feedback that matches the vision—empathetic, effective, always-on support. If you’re a health plan, integrated system, employer, or funder who wants measurable outcomes in addictions and chronic-condition adherence, let’s talk. Pilot slots are open.